We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Pioneering Hospital Group to Build New Medical Center in Dubai

By LabMedica International staff writers
Posted on 24 Feb 2014
Print article
Saudi-based Dr. Soliman Fakeeh Hospital (DSFH; Jeddah, Saudi Arabia) has announced plans to build, at an estimated AED 1 billion, a university and hospital in Dubai (UAE) Silicon Oasis (DSO). DSFH is one of the largest private hospitals in the Middle East with a total bed capacity of 600. DSFH has been a leader that has helped advance by leaps the standards of healthcare delivery in the Saudi Arabia and in the region.

DSFH's project in Dubai is expected to boost medical tourism in the United Arab Emirates (UAE) while addressing the shortage of skilled healthcare staff in the region. Construction will be carried out in phases with the 300-bed hospital scheduled to be completed by 2017, and the medical university by 2019. Built across 150,000 square meters, the hospital university project is expected to offer 4,000 new jobs, according to DSFH.

“The initiative is also a step forward in the implementation of the strategy of the Executive office to make Dubai a hub for medical tourism,” said Dr. Mohammed Al Zarooni, vice chairman and the CEO of the DSO Authority. “Recent statistics show that the number of medical tourists receiving treatment is estimated to increase by 15% each year. Additionally, healthcare spending in the UAE is expected to reach AED 40 billion by 2015, while medical tourists are set to cross the 20 million mark for the same period.” Also, a recent Ernst & Young report on the Gulf Cooperation Council (GCC) countries' healthcare industry called for more skilled local professionals to reduce reliance on expatriate staff, and noted that the region’s healthcare industry is seeing a rise in the number of private investors.

The new hospital, offering secondary and tertiary medical service, will mainly target the growing residence community in DSO and neighboring areas. The 300-bed facility is expected to cater to around 700,000 patients a year, with an estimated 40,000 admissions and 20,000 surgical operations.

Fakeeh Medical University (FMU), which will be built alongside the hospital, will offer instructions in fields such as medicine, nursing, laboratory sciences, radiology, physiotherapy, dentistry, clinical pharmacy, and health policy and management. The project will also include a basic sciences research and development center to develop innovations in the medical field. To encourage collaboration between medical professionals, FMU will partner with local universities, including the Rochester Institute of Technology in DSO; American University of Sharjah; Al Ain University and Dubai Academic City.

“This project will certainly tick all the boxes through value health treatments, best medical advice, job creation, and most importantly the creation of a dependable knowledge in the health field that will benefit this region,” said Dr. Al Zarooni.

Related Links:

Dr. Soliman Fakeeh Hospital

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.